All Stories

  1. HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites
  2. IL-10-Secreting CD8+ T Cells Specific for Human Cytomegalovirus (HCMV): Generation, Maintenance and Phenotype
  3. Antiviral activity of Cytomegalovirus-specific CD4+ T cells against lytically infected non-haemopoietic cells
  4. Spontaneous, persistent T-cell dependent IFN-γ release in patients who progress to Long COVID
  5. Spontaneous, persistent T-cell dependent IFN-γ release in patients who progress to Long COVID
  6. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses
  7. SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
  8. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
  9. SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
  10. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
  11. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
  12. A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells
  13. Microbial communities and their characteristics in cities around the world
  14. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
  15. Single-cell multi-omics analysis of the immune response in COVID-19
  16. Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation
  17. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
  18. A novel therapeutic approach to reduce post-transplant patient disease from human cytomegalovirus.
  19. SARS-CoV-2 evolution during treatment of chronic infection
  20. Age-related heterogeneity in immune responses to SARS-CoV-2 vaccine BNT162b2
  21. Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19
  22. Using Primary Human Cells to Analyze Human Cytomegalovirus Biology
  23. Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay
  24. The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People
  25. Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging
  26. An iPSC-Derived Myeloid Lineage Model of Herpes Virus Latency and Reactivation
  27. Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection
  28. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
  29. Extracellular Lactate: A Novel Measure of T Cell Proliferation
  30. Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection
  31. Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
  32. CMV immune evasion and manipulation of the immune system with aging
  33. Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro
  34. Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells
  35. The Characterization of Varicella Zoster Virus–Specific T Cells in Skin and Blood during Aging
  36. Latency-Associated Viral Interleukin-10 (IL-10) Encoded by Human Cytomegalovirus Modulates Cellular IL-10 and CCL8 Secretion during Latent Infection through Changes in the Cellular MicroRNA hsa-miR-92a
  37. Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes
  38. Diverse Specificities, Phenotypes, and Antiviral Activities of Cytomegalovirus-Specific CD8+ T Cells
  39. Human Cytomegalovirus Latency-Associated Proteins Elicit Immune-Suppressive IL-10 Producing CD4+ T Cells
  40. Investigation of the cutaneous response to recall antigen in humansin vivo
  41. Human cytomegalovirus immunity and immune evasion
  42. Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+ CD45RA+ CD27− T cells: the potential involvement of interleukin-7 in this process
  43. Different Proliferative Potential and Migratory Characteristics of Human CD4+ Regulatory T Cells That Express either CD45RA or CD45RO
  44. Cytomegalovirus Infection Reduces Telomere Length of the Circulating T Cell Pool
  45. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells
  46. Cytomegalovirus-Specific CD4+ T Cells in Healthy Carriers Are Continuously Driven to Replicative Exhaustion
  47. Telomere Erosion in Memory T Cells Induced by Telomerase Inhibition at the Site of Antigenic Challenge In Vivo